Attached files

file filename
EX-2.1 - United Royale Holdings Corp.ex2-1.htm
8-K - United Royale Holdings Corp.form8-k.htm

 

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

On September 30, 2018, United Royale Holdings Corp. (“URYL” or the “Company”) and Mr. CHEN Zheru (“Seller”), representing the sole shareholder of IV Enterprises Development Limited, a Seychelles corporation (“IVED”), entered into a Sale and Purchase Agreement, pursuant to which URYL acquired 100% (one hundred percent) of the shareholding of IVED. In consideration for the transfer by Seller to URYL of the Share and the Purchased Assets, URYL shall assume the Assumed Liabilities and pay to Seller US$1 in cash at Closing.

 

The following unaudited pro forma condensed consolidated financial statements have been derived by the application of adjustments to the Company’s historical consolidated financial statements. The unaudited pro forma condensed consolidated financial statements of income for the six months ended June 30, 2018 and for the fiscal year ended December 31, 2017 are presented as if the acquisition had occurred on January 1, 2017. The unaudited pro forma condensed consolidated balance sheets as of June 30, 2018 and December 31, 2017 are presented as if the acquisition had occurred on January 1, 2017.

 

Historical financial information for the fiscal year ended December 31, 2017 has been derived from audited historical consolidated financial statements included in the Company’s 2017 Annual Report on Form 10-K. Historical financial information for the Company as of and for the six months ended June 30, 2018 has been derived from unaudited historical consolidated condensed financial statements included in the Company’s Quarterly Report on Form 10-Q.

 

The unaudited pro forma condensed consolidated balance sheets and condensed consolidated statements of income are provided for informational purposes only and should not be construed to be indicative of the Company’s consolidated financial position or results of operations had the transaction been consummated on the date assumed and do not project the Company’s consolidated financial position or results of operations for any future period or date.

 

The unaudited pro forma consolidated balance sheets and unaudited pro forma consolidated statements of income were derived by adjusting the Company’s historical consolidated financial statements for the acquisition of IVED. The unaudited pro forma condensed combined statements of income do not include the impact of any potential cost savings or one-time costs that may result from the acquisition.

 

 
 

 

UNITED ROYALE HOLDINGS CORP.

UNAUDITED PRO FORMA

CONDENSED CONSOLIDATED STATEMENT OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   As Reported   Pro Forma Adjustments   Pro Forma 
             
Revenue  $-   $-   $- 
                
Cost of revenue   -    -    - 
                
Gross Profit   -    -    - 
                
Operating expenses               
- General and Administrative   (75,121)   (7,339)(a)   (82,460)
               
Loss From Operations   (75,121)   (7,339)   (82,460)
                
Foreign currency loss and other income (expense), net   59    -    59 
                
Loss Before Income Tax   (75,062)   (7,339)   (82,401)
                
Income tax expense   -    -    - 
                
Net Loss  $(75,062)  $(7,339)  $(82,401)
                
Net Loss per share:               
Basic and diluted  $(0.00)   -   $(0.00)
                
Weighted-average common shares outstanding:               
Basic and diluted   141,965,520    -    141,965,520 

 

The accompanying notes are an integral part of this unaudited pro forma consolidated financial statements

 

 
 

 

UNITED ROYALE HOLDINGS CORP.

UNAUDITED PRO FORMA

CONDENSED CONSOLIDATED STATEMENT OF INCOME

FOR THE YEAR ENDED DECEMBER 31, 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

    As Reported     Pro Forma Adjustments     Pro Forma  
                   
Revenue   $ 12,500     $ -     $ 12,500  
                         
Cost of revenue     (10,000 )     -       (10,000 )
                         
Gross Profit     2,500       -       2,500  
                         
Operating expenses                        
- General and Administrative     (45,003 )    

(22,608

) (a)   (67,611 )
                         
Loss From Operations     (42,503 )     (22,608 )     (65,111 )
                         
Foreign currency loss and other income (expense), net     (147 )     -       (147 )
                         
Loss Before Income Tax     (42,650 )     (22,608 )     (65,258 )
                         
Income tax expense     -       -       -  
                         
Net Loss   $ (42,650 )   $ (22,608 )   $ (65,258 )
                         
Net Loss per share:                        
Basic and diluted   $ (0.00 )     -     $ (0.00 )
                         
Weighted-average common shares outstanding:                        
Basic and diluted     198,677,849       -       198,677,849  

 

The accompanying notes are an integral part of this unaudited pro forma consolidated financial statements

 

 
 

 

UNITED ROYALE HOLDINGS CORP.

UNAUDITED PRO FORMA

CONDENSED CONSOLIDATED BALANCE SHEET

AS OF JUNE 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of share)

 

    As Reported     Pro Forma Adjustments       Pro Forma  
                   
ASSETS                        
CURRENT ASSETS                        
Cash and cash equivalents   $ 352,603     $ 27,237 (b)   $ 379,840  
Prepaid expenses     5,275       1,643 (c)     6,918  
TOTAL CURRENT ASSETS     357,878       28,880       386,758  
                         
NON-CURRENT ASSETS:                        
Plant and equipment, net     2,585       1,578 (d)     4,163  
Biological Assets     -       24,455 (e)     24,455  
                         
TOTAL ASSETS   $ 360,463     $ 54,913     $ 415,376  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY                        
CURRENT LIABILITIES:                        
Accrued liabilities   $ 9,300     $ 297 (f)   $ 9,597  
Due to Director     4,028       88,622 (g)     92,650  
TOTAL CURRENT LIABILITIES     13,328       88,919       102,247  
TOTAL LIABILITIES     13,328       88,919       102,247  
                         
STOCKHOLDERS’ DEFICIT:                        
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding     -               -  
Common stock, $ 0.0001 par value; 600,000,000 shares authorized; 141,965,520 shares issued and outstanding as of June 30, 2018     14,197       -       14,197  
Additional paid-in capital     643,448       -       643,448  
Accumulated other comprehensive income     -       180 (h)     180  
Accumulated deficit     (310,510 )     (34,186 )(i)     (344,696 )
TOTAL STOCKHOLDERS’ DEFICIT     347,135       (34,006 )     313,129  
                         
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 360,463     $ 54,913     $ 415,376  

 

The accompanying notes are an integral part of this unaudited pro forma consolidated financial statements

 

 
 

 

UNITED ROYALE HOLDINGS CORP.

UNAUDITED PRO FORMA

CONDENSED CONSOLIDATED BALANCE SHEET

AS OF DECEMBER 31, 2017

(Currency expressed in United States Dollars (“US$”), except for number of share)

 

    As Reported     Pro Forma Adjustments     Pro Forma  
                   
ASSETS                      
CURRENT ASSETS                      
Cash and cash equivalents   $ 440,868     $ 7,815 (b)   $ 448,683  
Prepaid expenses     425       1,640 (c)     2,065  
TOTAL CURRENT ASSETS     441,293       9,455       450,748  
                         
NON-CURRENT ASSETS:                        
Plant and equipment, net     3,232       1,667 (d)     4,899  
Biological Assets     -       24,395 (e)     24,395  
                         
TOTAL ASSETS   $ 444,525     $ 35,517     $ 480,042  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY                        
CURRENT LIABILITIES:                        
Accrued liabilities   $ 18,300     $ 296 (f)   $ 18,596  
Due to Director     4,028       62,009 (g)     66,037  
TOTAL CURRENT LIABILITIES     22,328       62,305       84,633  
TOTAL LIABILITIES     22,328       62,305       84,633  
                         
STOCKHOLDERS’ DEFICIT:                        
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding     -               -  
Common stock, $ 0.0001 par value; 600,000,000 shares authorized; 141,965,520 shares issued and outstanding as of December 31, 2017     14,197       -       14,197  
Additional paid-in capital     643,448       -       643,448  
Accumulated other comprehensive loss     -       (1,230 )(h)     (1,230 )
Accumulated deficit     (235,448 )     (25,558 )(i)     (261,006 )
TOTAL STOCKHOLDERS’ DEFICIT     422,197       (26,788 )     395,409  
                         
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 444,525     $ 35,517     $ 480,042  

 

 
 

 

NOTES TO THE UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The unaudited pro forma condensed consolidated statements of income for the six months ended June 30, 2018 and for the fiscal year ended December 31, 2017 are presented as if the acquisition had occurred on January 1, 2017. The unaudited pro forma condensed consolidated balance sheets as of June 30, 2018 and December 31, 2017 are presented as if the acquisition had occurred on January 1, 2017.

 

The unaudited pro forma condensed consolidated financial statements reflect the following adjustments:

 

(a)Reflect the adjustment to general and administrative expense incurred by IVED and its subsidiaries
(b)Reflect the adjustment to cash and cash equivalent being held by IVED and its subsidiaries
(c)Reflect the adjustment to current assets of prepayments and deposits owned by IVED and its subsidiaries
(d)Reflect the adjustment to plant and equipment owned by IVED and its subsidiaries
(e)Reflect the adjustment to non-current assets of biological assets owned by IVED and its subsidiaries
(f)Reflect the adjustment to current liabilities of accrued liabilities being held by IVED and its subsidiaries
(g)Reflect the adjustment to amount due to a director held by IVED and its subsidiaries
(h)Reflect the adjustment to the accumulated other comprehensive income made by IVED and its subsidiaries
(i)Reflect the adjustment to the accumulated deficit made by IVED and its subsidiaries